Only 1% of tumor cells need to express detectable ER+ to be considered ER+ breast cancers [120], and recent single-cell analyses have illuminated the heterogeneity of the tumor parenchyma and local stromal environments [44,45,68,80]. The gene discussed is ESR1; the disease is neoplasm.